General Electric Co. Stock Underperforms Monday When Compared To Competitors

Enzolytics Inc

Change company Symbol lookup

Select an option...

ENZC Enzolytics Inc

GREE Greenidge Generation Holdings Inc

MLM Martin Marietta Materials Inc

ERESW East Resources Acquisition Equity Warrant Exp 1st July 2027 *W EXP 07/01/2027

NRAC Noble Rock Acquisition Corp

DCGO DocGo Inc

VELOW Velocity Acquisition Equity Warrant Exp 24 Feb 2028 *W EXP 02/24/2028

MRC MRC Global Inc

BAC Bank of America Corp

BKR Baker Hughes Co

Company profile

Enzolytics, Inc. is a drug development biotechnology company. The Company is engaged in the commercialization of its proteins for the treatment of debilitating infectious diseases. The Company is focused in developing monoclonal antibody therapy and treating infectious diseases. It has anti-HIV therapeutics and a methodology for producing fully human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The Company has clinically tested anti-HIV therapeutics. The Company has developed a cell line that produces fully human monoclonal antibodies that target and neutralizes the HIV virus. The Company has also created human cell lines that produce human antibodies against other infectious diseases, including rabies, influenza, tetanus, and diphtheria. The Company is testing these antibodies to prepare them for use as therapies against these diseases.

General Electric Co. Stock Underperforms Monday When Compared To Competitors

4:56 pm ET January 10, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of General Electric Co. (GE) shed 1.95% to $99.42 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.14% to 4,670.29 and Dow Jones Industrial Average falling 0.45% to 36,068.87. The stock's fall snapped a two-day winning streak. General Electric Co. closed $16.75 below its 52-week high ($116.17), which the company achieved on November 9th.

The stock underperformed when compared to some of its competitors Monday, as Thermo Fisher Scientific Inc. (TMO) rose 2.96% to $625.04, Medtronic PLC (MDT) rose 0.44% to $105.62, and Danaher Corp. (DHR) rose 2.49% to $303.03. Trading volume (5.7 M) remained 894,681 below its 50-day average volume of 6.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 10, 2022.

-MarketWatch Automation

(END) Dow Jones Newswires

January 10, 2022 16:56 ET (21:56 GMT)